Results 301 to 310 of about 162,494 (358)

Four-Factor Prothrombin Complex Concentrate Administration Timing in Oral Anticoagulant-Associated Intracranial Hemorrhage. [PDF]

Hosp Pharm
Scott M, Schultheis J, Kram S, Sigmon J, Lee HJ, Dombrowski K.   +5 more
europepmc   +1 more source

Complex Investigation of the Similarities and Differences between Ten Commercially Available Human Serum Albumin Preparations. [PDF]

ACS Omega
Jakabfi-Csepregi R, Nagymihály Z, Horváth-Szalai Z, Szirmay B, Varga-Visi É, Ali O, Agyarko E, Szabó A, Poór M.   +8 more
europepmc   +1 more source

NOACs versus warfarin in people with atrial fibrillation and thyroid dysfunction. [PDF]

Medicine (Baltimore)
Tan L, Feng J, Xiong B, Xiong G, Zhu X, Jian J, Song Y, Zhou H.   +7 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya. [PDF]

Clin Drug Investig
O'Neill ET, Huang AW, Wilson-Barthes M, Manji I, Kigen G, Busakhala N, Nyanje S, Galárraga O, Pastakia SD.   +8 more
europepmc   +1 more source

The impact of chronic kidney disease on the antithrombotic strategies and outcomes in patients with acute coronary syndromes and atrial fibrillation: Insights from STAR-ACS study. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Yasuda K, Iwata H, Miyauchi K, Nojiri S, Nishizaki Y, Chikata Y, Minamino T, Daida H, STAR-ACS investigators.   +8 more
europepmc   +1 more source

UEG Week 2025 Moderated Posters

United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source